Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential ...

New research links early menopause and shorter reproductive years to a higher risk of ACPA-negative inflammatory arthritis in postmenopausal women, suggesting a critical role for oestrogen in ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential for healthcare implementation.

Scientists have discovered that a specific type of bacteria found in the gut may play a key role in triggering rheumatoid ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew ...

Truist notes that AnaptysBio (ANAB) reported the “much anticipated” results of its Phase 2b trial of rosnilimab for moderate-to-severe ...

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

AnaptysBio shares surged 37% in premarket trading Wednesday after a mid-stage trial evaluating a rheumatoid arthritis treatment achieved its primary endpoint. Shares were recently trading around $17.

A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA) and cognitive decline in dementia ...

A team of scientists from the University of Colorado has made an important discovery that could change how we understand and ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...